Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
68Ga-NODAGA-RGD PET/CT
DRUG
3 trials
Sponsors
University of Lausanne Hospitals
Conditions
Atheromatous Plaques
Carotid Artery Diseases
Chronic Ischemic Heart Disease
Inflammation
Myocardial Infarction, Acute
Myocardial Reperfusion
Pathological Angiogenesis
Phase 1
Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque
Terminated
NCT01608516
University of Lausanne Hospitals
Atheromatous Plaques, Carotid Artery Diseases, Inflammation
Start: 2012-04-01
End: 2026-07-01
Target: 20
Updated: 2026-07-16
68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis
Terminated
NCT02666547
University of Lausanne Hospitals
Pathological Angiogenesis
Start: 2014-03-31
End: 2023-09-30
Updated: 2024-06-20
Unknown Phase
Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET
Terminated
NCT03809689
University of Lausanne Hospitals
Chronic Ischemic Heart Disease, Myocardial Infarction, Acute, Myocardial Reperfusion
Start: 2018-11-01
End: 2023-10-11
Updated: 2024-06-20
Related Papers
Comparison of integrin αvβ3 expression with 68Ga-NODAGA-RGD PET/CT and glucose metabolism with 18F-FDG PET/CT in esophageal or gastroesophageal junction cancers
European Journal of Hybrid Imaging
2023-01-31
1 citations
Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study
EJNMMI Research
2020-05-07
28 citations
First in-human radiation dosimetry of <sup>68</sup>Ga-NODAGA-RGDyK.
2017-05-18
15 citations